Canada markets closed

CanSino Biologics Inc. (CASBF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.10000.0000 (0.00%)
At close: 11:28AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.18B
Enterprise Value 917.01M
Trailing P/E 10.28
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)10.47
Price/Book (mrq)0.74
Enterprise Value/Revenue 2.55
Enterprise Value/EBITDA -0.49

Trading Information

Stock Price History

Beta (5Y Monthly) 0.58
52-Week Change 3-53.33%
S&P500 52-Week Change 322.38%
52 Week High 34.5000
52 Week Low 31.8600
50-Day Moving Average 32.0949
200-Day Moving Average 32.7694

Share Statistics

Avg Vol (3 month) 3358
Avg Vol (10 day) 3N/A
Shares Outstanding 5132.67M
Implied Shares Outstanding 6561.44M
Float 8162.39M
% Held by Insiders 126.70%
% Held by Institutions 115.11%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Jul 13, 2022
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-527.50%

Management Effectiveness

Return on Assets (ttm)-10.36%
Return on Equity (ttm)-31.40%

Income Statement

Revenue (ttm)357.08M
Revenue Per Share (ttm)1.45
Quarterly Revenue Growth (yoy)-44.50%
Gross Profit (ttm)N/A
EBITDA -1.48B
Net Income Avi to Common (ttm)-1.48B
Diluted EPS (ttm)-0.8500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.13B
Total Cash Per Share (mrq)16.72
Total Debt (mrq)2.7B
Total Debt/Equity (mrq)51.06%
Current Ratio (mrq)2.02
Book Value Per Share (mrq)21.35

Cash Flow Statement

Operating Cash Flow (ttm)-908.23M
Levered Free Cash Flow (ttm)-846.51M